131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma
Clinical trial NCT03649438 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03649438
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.